• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠内营养为腹膜假黏液瘤患者提供良好的术后预后:一项回顾性研究。

Enteral nutrition provides favorable postoperative outcomes for patients with pseudomyxoma peritonei: a retrospective study.

作者信息

Kuang Xuechun, She Guie, Shi Yanhui, Yang Zhiyou, Li Jun, Zhang Zhipeng

机构信息

Department of Geratology Surgery, Xiangya Hospital, Central South University, Changsha, China.

Teaching and Research Section of Clinical Nursing, Xiangya Hospital, Central South University, Changsha, China.

出版信息

Gland Surg. 2022 May;11(5):818-825. doi: 10.21037/gs-22-170.

DOI:10.21037/gs-22-170
PMID:35694101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9177278/
Abstract

BACKGROUND

Pseudomyxoma peritonei (PMP) is a rare malignancy, and many uncertainties regarding its treatment and prognosis still remain. The main treatment for PMP is cytoreductive surgery (CRS) combined with heated intraperitoneal chemotherapy (HIPEC), which can lead to intra-abdominal trauma and systemic reactions. Enteral nutrition (EN) is an important and beneficial perioperative option for major complicated abdominal surgery compared with total parenteral nutrition (TPN). However, the role of EN in PMP after surgery is still unknown. The purpose of this study was to analyze the effects of EN on postoperative outcomes in PMP patients.

METHODS

The perioperative clinical data of PMP patients from Xiangya Hospital of Central South University who accepted CRS plus HIPEC from January 2011 to December 2018 were collected and analyzed. The effects of EN on the nutritional status, postoperative complications, and hospital stay time of patients with PMP were studied. We further analyzed the risk factors affecting hospital stay and complications in PMP patients after surgery.

RESULTS

A total of 51 PMP patients accepted CRS and were enrolled in this study, including 25 cases in the EN group and 26 patients in the TPN group. The baseline demographic characteristics and preoperative nutritional status were not significantly different between the two groups. The postoperative absolute lymphocyte count (P<0.001), hemoglobin (P=0.016), and albumin (P<0.001) levels of the EN group were higher than those of the TPN group, but the postoperative hospital stay time (P=0.008) and the complication rate (P=0.03) in the EN group were less than those in the TPN group. Logistic regression analysis showed that age (P=0.031), American Society of Anesthesiologists (ASA) score (P=0.008), and EN (P=0.024) were independent risk factors for postoperative hospital stay in PMP patients. ASA score (P=0.006), number of prior operations (P=0.021), and EN (P=0.035) were independent risk factors for postoperative complications in PMP patients.

CONCLUSIONS

EN support results in better outcomes and is an independent protective factor for the postoperative hospital stay time and complications of PMP patients.

摘要

背景

腹膜假黏液瘤(PMP)是一种罕见的恶性肿瘤,其治疗和预后仍存在许多不确定性。PMP的主要治疗方法是减瘤手术(CRS)联合热灌注化疗(HIPEC),这可能导致腹腔内创伤和全身反应。与全肠外营养(TPN)相比,肠内营养(EN)是重大复杂腹部手术围手术期重要且有益的选择。然而,EN在PMP术后的作用仍不清楚。本研究的目的是分析EN对PMP患者术后结局的影响。

方法

收集并分析2011年1月至2018年12月在中南大学湘雅医院接受CRS加HIPEC的PMP患者的围手术期临床资料。研究EN对PMP患者营养状况、术后并发症及住院时间的影响。我们进一步分析了影响PMP患者术后住院时间和并发症的危险因素。

结果

共有51例PMP患者接受CRS并纳入本研究,其中EN组25例,TPN组26例。两组患者的基线人口统计学特征和术前营养状况无显著差异。EN组术后绝对淋巴细胞计数(P < 0.001)、血红蛋白(P = 0.016)和白蛋白(P < 0.001)水平高于TPN组,但EN组术后住院时间(P = 0.008)和并发症发生率(P = 0.03)低于TPN组。Logistic回归分析显示,年龄(P = 0.031)、美国麻醉医师协会(ASA)评分(P = 0.008)和EN(P = 0.024)是PMP患者术后住院时间的独立危险因素。ASA评分(P = 0.006)、既往手术次数(P = 0.021)和EN(P = 0.035)是PMP患者术后并发症的独立危险因素。

结论

EN支持可带来更好的结局,是PMP患者术后住院时间和并发症的独立保护因素。

相似文献

1
Enteral nutrition provides favorable postoperative outcomes for patients with pseudomyxoma peritonei: a retrospective study.肠内营养为腹膜假黏液瘤患者提供良好的术后预后:一项回顾性研究。
Gland Surg. 2022 May;11(5):818-825. doi: 10.21037/gs-22-170.
2
Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center.阑尾来源的假性黏液瘤行细胞减灭术加腹腔内热灌注化疗后的围手术期安全性:单中心 254 例患者的经验。
Eur J Surg Oncol. 2020 Apr;46(4 Pt A):600-606. doi: 10.1016/j.ejso.2020.01.017. Epub 2020 Jan 15.
3
The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.腹腔内热灌注化疗在细胞减灭术后假性黏液瘤中的作用。
JAMA Surg. 2021 Mar 1;156(3):e206363. doi: 10.1001/jamasurg.2020.6363. Epub 2021 Mar 10.
4
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study.阑尾来源的假性黏液瘤行细胞减灭术(CRS)和腹腔内热灌注化疗(HIPEC):单中心研究结果。
Updates Surg. 2020 Dec;72(4):1207-1212. doi: 10.1007/s13304-020-00788-5. Epub 2020 May 14.
5
Early Postoperative Intraperitoneal Chemotherapy for Low-Grade Appendiceal Mucinous Neoplasms with Pseudomyxoma Peritonei: Is it Beneficial?低级别阑尾黏液性肿瘤伴腹膜假黏液瘤的术后早期腹腔内化疗:是否有益?
Ann Surg Oncol. 2017 Jan;24(1):176-183. doi: 10.1245/s10434-016-5529-0. Epub 2016 Oct 7.
6
Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma.腹腔镜细胞减灭术和 HIPEC 治疗低度假黏液瘤腹膜和多房性间皮瘤的疗效观察。
Surg Endosc. 2020 Nov;34(11):4916-4923. doi: 10.1007/s00464-019-07280-1. Epub 2019 Dec 2.
7
[The perioperative safety of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei].[细胞减灭术联合腹腔热灌注化疗治疗腹膜假黏液瘤的围手术期安全性]
Zhonghua Zhong Liu Za Zhi. 2020 May 23;42(5):419-424. doi: 10.3760/cma.j.cn112152-112152-20190430-00278.
8
[A single-center clinical analysis of 65 cases of pseudomyxoma peritonei from appendiceal origin in the early stage].[65例阑尾源性早期腹膜假黏液瘤的单中心临床分析]
Zhonghua Zhong Liu Za Zhi. 2019 Sep 23;41(9):698-702. doi: 10.3760/cma.j.issn.0253-3766.2019.09.010.
9
Preoperative carcinoembryonic antigen level predicts prognosis in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.术前癌胚抗原水平可预测接受细胞减灭术和腹腔热灌注化疗治疗假性黏液瘤腹膜的患者的预后。
World J Surg. 2013 Jun;37(6):1271-6. doi: 10.1007/s00268-013-1988-7.
10
Clinicopathological features and prognosis of pseudomyxoma peritonei.腹膜假黏液瘤的临床病理特征及预后
Exp Ther Med. 2014 Jan;7(1):185-190. doi: 10.3892/etm.2013.1408. Epub 2013 Nov 13.

引用本文的文献

1
Nursing care for cytoreduction and hyperthermic intraoperative chemotherapy in an Intensive Care Unit: a scoping review.重症监护病房中细胞减灭术和高热术中化疗的护理:范围综述。
Rev Esc Enferm USP. 2024 Nov 25;58:e20240176. doi: 10.1590/1980-220X-REEUSP-2024-0176en. eCollection 2024.
2
The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing cytoreductive surgery: a retrospective study.接受肿瘤细胞减灭术的癌症患者基线营养状况与后续肠外营养及临床结局之间的关系:一项回顾性研究。
Front Nutr. 2024 May 3;11:1364959. doi: 10.3389/fnut.2024.1364959. eCollection 2024.
3
Nutrition Care for the Patient Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.接受减瘤手术联合腹腔热灌注化疗患者的营养护理
Support Line (Chic). 2024 Feb;46(1):2-10.

本文引用的文献

1
Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results.细胞减灭术和腹腔热灌注化疗治疗胃癌腹膜疾病:PERISCOPE I 的初步结果。
Br J Surg. 2020 Oct;107(11):1520-1528. doi: 10.1002/bjs.11588. Epub 2020 Apr 11.
2
Update on the management of malignant peritoneal mesothelioma.恶性腹膜间皮瘤管理的最新进展
Transl Lung Cancer Res. 2018 Oct;7(5):599-608. doi: 10.21037/tlcr.2018.08.03.
3
Peritoneal Metastases, a Frontier for Progress.腹膜转移,进展前沿。
Surg Oncol Clin N Am. 2018 Jul;27(3):413-424. doi: 10.1016/j.soc.2018.02.001.
4
Enteral nutrition improves clinical outcome and reduces costs of acute mesenteric ischaemia after recanalisation in the intensive care unit.肠内营养可改善重症监护病房急性肠系膜缺血再通后的临床结局并降低成本。
Clin Nutr. 2019 Feb;38(1):398-406. doi: 10.1016/j.clnu.2017.12.008. Epub 2017 Dec 20.
5
Nutritional assessment methods as predictors of postoperative mortality in gastric cancer patients submitted to gastrectomy.营养评估方法作为接受胃切除术的胃癌患者术后死亡率的预测指标。
Rev Col Bras Cir. 2017 Sep-Oct;44(5):482-490. doi: 10.1590/0100-69912017005010.
6
Pseudomyxoma peritonei: natural history and treatment.腹膜假黏液瘤:自然病史与治疗。
Int J Hyperthermia. 2017 Aug;33(5):511-519. doi: 10.1080/02656736.2017.1310938.
7
Parenteral Nutrition: Amino Acids.肠外营养:氨基酸
Nutrients. 2017 Mar 10;9(3):257. doi: 10.3390/nu9030257.
8
Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines.危重症患者的早期肠内营养:欧洲重症监护医学学会临床实践指南
Intensive Care Med. 2017 Mar;43(3):380-398. doi: 10.1007/s00134-016-4665-0. Epub 2017 Feb 6.
9
Recent Advances in Enteral Nutrition.肠内营养的最新进展。
Nutrients. 2016 Nov 8;8(11):709. doi: 10.3390/nu8110709.
10
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care.细胞减灭术和腹腔热灌注化疗治疗胃肠道癌腹膜转移:迈向新的治疗标准的进展。
Cancer Treat Rev. 2016 Jul;48:42-9. doi: 10.1016/j.ctrv.2016.06.007. Epub 2016 Jun 16.